Publication

Article Metrics

Citations


Online attention

Diamond: shedding light on structure-based drug discovery

DOI: 10.1098/rsta.2014.0468 DOI Help
PMID: 25624512 PMID Help

Authors: David G. Brown (University of Kent) , Elizabeth Shotton (Diamond Light Source)
Co-authored by industrial partner: Yes

Type: Journal Paper
Journal: Philosophical Transactions Of The Royal Society A: Mathematical, Physical And Engineering Sciences , VOL 373 , PAGES 20140468 - 20140468

State: Published (Approved)
Published: January 2015

Abstract: Structure-based drug design has become a key tool for the development of novel drugs. The process involves elucidating the three-dimensional structure of the potential drug molecule bound to the target protein that has been identified as playing a key role in the disease state. Using this three-dimensional information facilitates the process of making improvements to the potential drug molecule by highlighting existing and possible new interactions within the binding site. This knowledge is used to inform increases in potency and selectivity of the molecules as well as to help improve other drug-like properties. The speed and numbers of samples that can be studied, combined with the improved resolution of the structures that can be obtained using synchrotron radiation, have had a significant impact on the utilization of crystallography in the drug discovery process.

Subject Areas: Biology and Bio-materials, Medicine


Technical Areas: